TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT06598969 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Myeloid Leukemia, Acute

Interventions

DRUG: Total bone marrow and lymphoid irradiation/cyclophosphamide/etoposide

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla